CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kachinskas, D. J.
Right arrow Articles by Rice, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kachinskas, D. J.
Right arrow Articles by Rice, R. H.

Cell Growth & Differentiation, Vol 5, Issue 11 1235-1241, Copyright © 1994 by American Association of Cancer Research

ARTICLES

Arsenate perturbation of human keratinocyte differentiation

DJ Kachinskas, MA Phillips, Q Qin, JD Stokes and RH Rice
Department of Environmental Toxicology, University of California, Davis 95616-8588.

Treatment of cultured malignant human keratinocytes with sodium arsenate greatly suppressed expression of involucrin, a specific marker of keratinocyte differentiation. This action was primarily attributable to inhibition of involucrin transcription according to message run-on and stability measurements. Involucrin was suppressed in nontumorigenic keratinocytes as well, although the efficacy of suppression was less dramatic in cells derived from clinically normal epidermis. Several transition metal oxyanions (vanadate, molybdate, and tungstate) also substantially suppressed involucrin expression, but okadaic acid was ineffective. Immunoblotting detected marked increases in tyrosine phosphorylation of several proteins as a consequence of arsenate treatment of the cultures, while mobility shift analysis revealed a dramatic loss of DNA binding by the transcription factor AP2. These findings support a proposed role for altered levels of protein tyrosine phosphorylation in keratinocyte differentiation. They also suggest that arsenate perturbs the differentiation program in target cells by altering this phosphorylation level and transcription factor activity.


This article has been cited by other articles:


Home page
 Toxicol SciHome page
E. M. Wauson, A. S. Langan, and R. L. Vorce
Sodium Arsenite Inhibits and Reverses Expression of Adipogenic and Fat Cell-Specific Genes during in Vitro Adipogenesis
Toxicol. Sci., February 1, 2002; 65(2): 211 - 219.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. R. Germolec, J. Spalding, H.-S. Yu, G. S. Chen, P. P. Simeonova, M. C. Humble, A. Bruccoleri, G. A. Boorman, J. F. Foley, T. Yoshida, et al.
Arsenic Enhancement of Skin Neoplasia by Chronic Stimulation of Growth Factors
Am. J. Pathol., December 1, 1998; 153(6): 1775 - 1785.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.